Edition:
United Kingdom

Oasmia Pharmaceutical AB (OASM.OQ)

OASM.OQ on NASDAQ Stock Exchange Capital Market

1.81USD
26 Apr 2018
Change (% chg)

$0.10 (+5.85%)
Prev Close
$1.71
Open
$1.75
Day's High
$1.81
Day's Low
$1.70
Volume
401
Avg. Vol
6,987
52-wk High
$3.10
52-wk Low
$0.80

Select another date:

Fri, Mar 2 2018

BRIEF-Oasmia Pharmaceutical Q3 sales rise, smaller operating loss

* Q3 ‍CONSOLIDATED NET SALES AMOUNTED TO TSEK 656 COMPARED TO TSEK 36 IN Q3 PREVIOUS YEAR​

BRIEF-Oasmia Pharma says all patients have been treated in two ongoing studies with Docecal

* REG-OASMIA PHARMACEUTICAL’S DOCECAL PROGRAM ACHIEVES SIGNIFICANT DEVELOPMENT MILESTONE

BRIEF-Oasmia receives marketing approval for Paclical in Kazakhstan

* OASMIA PHARMACEUTICAL RECEIVES MARKETING APPROVAL FOR PACLICAL® IN KAZAKHSTAN Source text for Eikon: Further company coverage: (Reporting by Stockholm Newsroom)

BRIEF-Oasmia Pharmaceutical Q2 operating loss shrinks

* OASMIA PHARMACEUTICAL AB Q2 ‍CONSOLIDATED NET SALES AMOUNTED TO TSEK 1,651 COMPARED TO TSEK 56 IN THE SECOND QUARTER THE PREVIOUS YEAR ​

BRIEF-Oasmia completes 28 mln SEK private placement of new convertible instruments

* OASMIA HAS COMPLETED A PRIVATE PLACEMENT OF NEW CONVERTIBLE INSTRUMENTS IN A TOTAL AMOUNT OF SEK 28,000,000

Select another date: